KEVIN MCGUINESS PLLC for TEVA PHARMACEUTICALS USA INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 19, 2009 | $37,500 | Replaced |
| 3rd Quarter - Report | Jan 19, 2010 | $35,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 515, the Patent Reform Act of 2009
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN MCGUINESS | — |
Health Issues HCR
S. 369, the Preserve Access to Affordable Generics Act H.R. 1427, the Promoting Innovation and Access to Life-Saving Medicine Act
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN MCGUINESS | — |
Labor Issues/Antitrust/Workplace LBR
S. 639, the Preserve Access to Affordable Generics Act
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as an indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KEVIN MCGUINESS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.